ClinConnect ClinConnect Logo
Search / Trial NCT02770417

Oral β-Alanine Supplementation in Patients With COPD

Launched by HASSELT UNIVERSITY · May 11, 2016

Trial Information

Current as of July 22, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • COPD: diagnosis of moderate to very severe COPD according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines
  • Healthy controls: forced expiratory volume at one second/forced vital capacity (FEV1/FVC) \> 0.7, matched for age and gender
  • Exclusion Criteria:
  • The presence of known instable cardiac disease
  • neurological disease and/or musculoskeletal disease that preclude safe participation in an exercise test
  • a history of drugs/alcohol abuse
  • vegetarianism
  • inability to understand the Flemish language.
  • COPD-specific exclusion criteria:
  • COPD exacerbation and/or hospitalization in the last 6 weeks
  • participation in pulmonary rehabilitation in the previous 12 months.

About Hasselt University

Hasselt University is a prestigious research institution located in Belgium, renowned for its commitment to advancing scientific knowledge and innovation. With a strong focus on interdisciplinary research, the university actively engages in clinical trials that aim to address pressing health challenges. Leveraging a robust network of collaborations with healthcare professionals, industry partners, and research organizations, Hasselt University strives to translate research findings into practical applications that benefit patient care and public health. The institution is dedicated to maintaining the highest ethical standards and regulatory compliance in all its clinical research endeavors.

Locations

Hasselt, , Belgium

Patients applied

0 patients applied

Trial Officials

Martijn Spruit, prof. dr.

Principal Investigator

Hasselt University

Jana De Brandt, drs

Study Chair

Hasselt University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials